Dave Coulier, "Full House" star, reveals battle with non-Hodgkin lymphoma

Dave Coulier, known for his role as Joey Gladstone on the sitcom "Full House," has revealed that he was diagnosed with non-Hodgkin lymphoma in 2019.

In an interview with People magazine, Coulier said he was diagnosed with stage 4 non-Hodgkin lymphoma, a type of cancer that starts in the lymphatic system. He underwent treatment for several months and is now in remission.

Coulier said he kept his diagnosis private at the time because he didn't want to worry his family and friends. He also said he wanted to focus on his treatment and recovery.

Now that he is in remission, Coulier said he is sharing his story to raise awareness about non-Hodgkin lymphoma. He also wants to encourage others who are battling cancer to stay positive and never give up.

What is non-Hodgkin lymphoma?

Non-Hodgkin lymphoma is a type of cancer that starts in the lymphatic system, a network of vessels and nodes that helps fight infection. Non-Hodgkin lymphoma can occur anywhere in the body, but it most commonly affects the lymph nodes, spleen, bone marrow, and digestive tract.

There are many different types of non-Hodgkin lymphoma, and each type has its own unique symptoms and treatment options. Some of the most common types of non-Hodgkin lymphoma include:

• Diffuse large B-cell lymphoma
• Follicular lymphoma
• Mantle cell lymphoma
• Burkitt lymphoma
• Hodgkin lymphoma

Symptoms of non-Hodgkin lymphoma

The symptoms of non-Hodgkin lymphoma can vary depending on the type of lymphoma and the location of the cancer. Some of the most common symptoms include:

• Swollen lymph nodes
• Fever
• Night sweats
• Weight loss
• Fatigue
• Shortness of breath
• Abdominal pain
• Nausea and vomiting

Treatment for non-Hodgkin lymphoma

The treatment for non-Hodgkin lymphoma depends on the type of lymphoma, the stage of the cancer, and the patient's overall health. Treatment options may include:

• Chemotherapy
• Radiation therapy
• Immunotherapy
• Targeted therapy
• Stem cell transplant

Outlook for non-Hodgkin lymphoma

The outlook for non-Hodgkin lymphoma depends on the type of lymphoma, the stage of the cancer, and the patient's overall health. The five-year survival rate for all types of non-Hodgkin lymphoma is about 70%. However, the survival rate for some types of non-Hodgkin lymphoma, such as diffuse large B-cell lymphoma, is much lower.

If you are diagnosed with non-Hodgkin lymphoma, it is important to work with your doctor to develop a treatment plan that is right for you. Treatment for non-Hodgkin lymphoma can be complex, but it is possible to achieve remission and live a long, healthy life.